CDEK
← All organizations

Alpine Immune Sciences

For profitWebsite ↗

Also known as: Alpine Immune Sciences | Alpine Immune Sciences, Inc.

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 2

First clinical trial

Jan 29, 2019

Last known activity

Jul 3, 2023

Acquired by Vertex → Henry Schein, Inc → Watson Pharmaceuticals → Actavis → Allergan PLC (2015) → AbbVie on Apr 11, 2024

Timeline

2010s

  1. Jan 1, 2015

    Alpine Immune Sciences— Founded

  2. Apr 18, 2017

    Nivalis Therapeutics, Inc.— Acquired

  3. Jun 26, 2019

    AbbVie— Now

2020s

  1. Apr 11, 2024

    Vertex— Acquired By

Drugs by trial phase (9 distinct, 19 trials)

Phase 2 (2 own, 2 via acquisition)

Phase 1 (2 own, 3 via acquisition)

Indications

Studied for

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Recent trials (13)

Details

Founded
Seattle, WA, US Jan 1, 2015
Last known activity
Jul 3, 2023